Vulvar keratoacanthoma is a rare skin growth on the vulva that often appears as a fast-growing lump with a central plug of keratin. The early symptoms of vulvar keratoacanthoma may include a tender or irritated bump, minor pain, or spotting from rubbing, and it usually affects older adults. It tends to develop over weeks, but not everyone will have the same experience. Doctors usually treat vulvar keratoacanthoma by removing it with surgery so they can confirm the diagnosis and rule out vulvar squamous cell carcinoma. Death from vulvar keratoacanthoma itself is not expected, but prompt medical evaluation matters because it can closely resemble a cancerous lesion.
How many people live with Vulvar keratoacanthoma?
Global and U.S. prevalence estimates for vulvar keratoacanthoma, a very rare skin growth on the vulva, are not consistently reported by a single authoritative source, and published information is limited mainly to individual case reports rather than population counts. Because of that, there is no reliable current estimate for how many people are living with it worldwide or in the United States.
Overview
Vulvar keratoacanthomaSymptoms
Vulvar keratoacanthoma usually appears as a fast-growing, dome-shaped lump on the vulva, often with a central plug of keratin. Some people notice tenderness, irritation, itching, or bleeding, while others have little pain.
Outlook and prognosis
For many living with vulvar keratoacanthoma, the outlook is usually very good after complete removal. Recurrence is uncommon, but follow-up matters because this fast-growing bump can closely resemble vulvar skin cancer.
Causes and risk factors
Vulvar keratoacanthoma likely arises from rapid overgrowth of skin cells, but the exact cause is unclear. Possible risk factors include older age, chronic irritation or minor injury, immune suppression, and sometimes genetic changes in the affected cells.
Genetic influences
Genetics are not thought to play a major role in vulvar keratoacanthoma. Most cases are not inherited, and no specific genetic variation is known to clearly cause it, though rare tumor-related DNA changes may be found.
Diagnosis
Vulvar keratoacanthoma is usually diagnosed with a pelvic exam and a small tissue sample, called a biopsy. Because it can look like other vulvar growths, the diagnosis of vulvar keratoacanthoma is confirmed by lab testing.
Treatment and drugs
Vulvar keratoacanthoma is usually treated by surgically removing the growth, both to relieve irritation and to confirm it is not a vulvar skin cancer. Follow-up checks help watch healing and make sure it does not come back.
Symptoms
A new bump on the vulva that seems to enlarge over a few weeks is often how vulvar keratoacanthoma first shows up. Among the early symptoms of vulvar keratoacanthoma, many people notice a firm, round growth that can become sore with friction from underwear, exercise, or sex. Some growths stay mostly painless, while others itch, crust, or bleed. Symptoms vary from person to person and can change over time.
The most common symptom is a single firm bump on the vulva that grows quickly over days to weeks. It often feels round or dome-shaped and stands out from the nearby skin.
Many people with vulvar keratoacanthoma feel soreness when the area is touched, wiped, or rubbed by clothing. For some, sitting, walking, exercise, or sex can become uncomfortable.
The skin over or around the bump can itch, sting, or feel irritated, especially if sweat or friction is present. Some may find that routine washing or wearing tighter underwear makes the discomfort more noticeable.
Some growths develop a rough center, a crust, or a small dip filled with hard skin material. This can make the area feel dry, irritated, or easier to catch on clothing.
How people usually first notice Vulvar keratoacanthoma?
People usually first notice vulvar keratoacanthoma as a new bump on the vulva that seems to appear quickly over a few weeks rather than slowly over many months. It often looks like a firm, round, dome-shaped lump and may have a central plug of keratin, a rough material that can look yellowish or crusted, and some people notice tenderness, irritation, itching, or minor bleeding from friction. Because the first signs of vulvar keratoacanthoma can resemble other vulvar growths, including skin cancer, a fast-growing vulvar lump should be checked by a clinician promptly.
Types of Vulvar keratoacanthoma
Vulvar keratoacanthoma is not usually divided into many formal subtypes, but doctors do recognize a few clinical variants based on how the lump looks and grows. In practice, the main types of vulvar keratoacanthoma differ mostly in size, number, and whether the bump tends to stay localized or spread outward at the edges. Symptoms do not always look the same for everyone.
Classic solitary
This is the most typical form, with a single fast-growing dome-shaped bump on the vulva that often has a central plug of keratin, a firm skin material. Many living with vulvar keratoacanthoma notice tenderness, irritation, or rubbing discomfort when walking, sitting, or wearing close-fitting underwear.
Giant variant
This less common form is much larger than the usual lesion and can cause more pain, pressure, or trouble with daily comfort. Because of its size and quick growth, it may look more concerning and can be harder to tell apart from vulvar squamous cell carcinoma without a biopsy.
Multiple lesions
Rarely, more than one keratoacanthoma-type lesion appears in the vulvar area or nearby skin. For many, this can mean irritation in more than one spot and a greater chance of confusing the condition with other skin problems that cause clusters of bumps.
Centrifugal variant
In this uncommon pattern, the lesion expands outward at the edges rather than staying as one rounded bump. Some may find that the area becomes broader and more bothersome over time, even if the center changes in a different way from the border.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of vulvar keratoacanthoma, which is a rare, fast-growing skin lump on the vulva, and researchers are still learning why it happens. There are no proven screening tests or preventive drugs for it, but it is important to have any new vulvar bump, sore, bleeding, or pain checked early because these growths can look like skin cancer and are usually treated by removing them. While you usually cannot prevent this condition, early care can help you get the right diagnosis and treatment sooner.
What genetics can tell you about symptoms
For vulvar keratoacanthoma, genetics usually does not tell doctors much about which symptoms will happen, how severe they will be, or when they will start. This rare growth is generally not linked to a clear inherited genetic pattern, and while changes inside the tumor cells may play a role in how it forms, they are not used in routine care to predict symptoms such as a quickly growing vulvar bump, tenderness, or irritation. In most cases, the symptoms and timing are judged more by the size, location, and growth of the lesion than by a person’s genes.
Causes and risk factors
Vulvar keratoacanthoma does not have one clear cause, but it seems to begin when skin cells in the vulva start growing too fast. The risk may be higher with older age, a weakened immune system, and smoking. Long-term irritation, friction, inflammation, or a small injury in the area may also play a part. It is rarely just one factor, and the mix matters. Most cases are not passed down in families, but gene changes can build up in skin cells over time.
What are the most common causes or risk factors?
The exact cause of vulvar keratoacanthoma is not clear, and in many people it shows up without one obvious reason. It may be more likely after ongoing irritation or a minor injury to the vulvar skin, and it seems to be seen more often in older adults and in people with a weakened immune system. Rarely, some families have an inherited tendency to develop this kind of fast-growing skin growth, but most cases are not clearly linked to a genetic cause.
Environmental and biological risk factors
Because it is rare, the risk factors for vulvar keratoacanthoma are not mapped out as clearly as they are for more common skin growths. Doctors often group risks into internal (biological) and external (environmental). In reported cases, vulvar keratoacanthoma seems to be linked most often to older age, local skin injury or irritation, and changes in immune function rather than one single cause.
Vulvar keratoacanthoma is reported more often in middle-aged and older adults. As skin ages, the chance of abnormal, fast cell growth tends to rise.
Minor trauma such as scratching, shaving cuts, friction, or a recent procedure can sometimes trigger this kind of lump. The growth may appear in an area that has been irritated or is still healing.
Ongoing vulvar irritation or long-term inflammatory skin problems may raise the risk of vulvar keratoacanthoma. Skin that is repeatedly inflamed spends more time repairing itself, which can increase the chance of abnormal growth.
People with reduced immune defenses, including some living with cancer, organ transplants, or immune-suppressing treatment, may have a higher risk of keratoacanthoma-type growths. A less active immune system can make it harder to clear unusual skin cells early.
Genetic risk factors
Vulvar keratoacanthoma usually does not have a clear inherited cause. Most cases appear to happen sporadically, which means they are not tied to a known gene passed down in families. Because this growth is rare, the genetic risk factors for vulvar keratoacanthoma are still being worked out. Rare inherited syndromes can raise the chance of keratoacanthoma-like skin tumors, but these are uncommon and not specific to the vulva.
No single gene: No single inherited gene change is known to commonly cause vulvar keratoacanthoma. For many living with this diagnosis, genetic testing is not part of routine care unless other clues suggest a broader inherited syndrome.
Rare syndromes: A few uncommon inherited syndromes can make keratoacanthoma-type skin growths more likely in some families. Carrying a genetic change doesn’t guarantee the condition will appear. These syndromes are rare and do not explain most vulvar keratoacanthoma cases.
Family history: Most people with vulvar keratoacanthoma do not report a strong family history of the same lesion. Still, several relatives with repeated keratoacanthoma-like growths can be a clue that an inherited tendency is worth checking.
Tumor cell changes: Doctors think many cases arise from DNA changes that develop only in the cells of the growth itself. These changes are different from inherited gene changes and usually are not passed from parent to child.
Lifestyle risk factors
Lifestyle risk factors for vulvar keratoacanthoma are not as well defined as they are for many common skin conditions because this lesion is rare. Still, some everyday habits may increase repeated irritation of vulvar skin, make symptoms worse, or delay healing after the lesion appears. In practice, how lifestyle affects vulvar keratoacanthoma is often through friction, skin injury, smoking, and delayed medical evaluation rather than through a single proven cause.
Smoking can impair blood flow and skin repair, which may worsen inflammation around a vulvar keratoacanthoma and slow healing after treatment. It may also increase the chance of ongoing irritation in already sensitive vulvar tissue.
Tight clothing, prolonged cycling, or frequent rubbing can repeatedly irritate vulvar skin. Ongoing friction may aggravate pain, tenderness, or local inflammation around the lesion.
Aggressive shaving, waxing, or picking at a vulvar bump can injure the skin and trigger more irritation. Self-treatment may also distort the lesion and delay proper diagnosis or removal.
Waiting to seek medical attention for a fast-growing vulvar nodule can allow discomfort, bleeding, or secondary irritation to worsen. Early assessment matters because vulvar keratoacanthoma can resemble other lesions that need different treatment.
Risk prevention
Because vulvar keratoacanthoma is rare, there is no proven way to fully prevent it. Prevention is about lowering risk, not eliminating it completely. In practice, that means protecting vulvar skin from ongoing irritation, lowering risks linked to smoking or HPV when relevant, and getting new lumps checked early so treatment can happen before the area becomes more painful or bothersome.
Ongoing friction, scratching, harsh soaps, and repeated skin injury may irritate vulvar tissue over time. Gentle skin care, breathable underwear, and prompt treatment of itching or rashes may help reduce this stress on the skin.
Smoking is linked to several vulvar skin and precancer problems, and it may add to overall risk in this area. If you smoke, stopping can support healthier skin and improve healing if a lesion appears.
Some vulvar growths are linked to human papillomavirus, although this link is not clear for every vulvar keratoacanthoma. HPV vaccination and safer sex practices can still help lower the risk of other vulvar cell changes that may look similar or occur nearby.
People with weakened immune systems can have a higher risk of unusual skin growths. Keeping long-term conditions well managed and reviewing immune-suppressing medicines with your doctor may help lower risk when possible.
Can you prevent Vulvar keratoacanthoma?
No, there is no sure or proven way to prevent vulvar keratoacanthoma, which is a rare skin growth on the vulva. Because it is so uncommon, doctors do not fully understand why it happens, and no specific prevention steps have been shown to stop it. In general, protecting the area from ongoing irritation may support skin health, but this has not been proven to prevent this condition.
Transmission
Vulvar keratoacanthoma is not contagious. It is not passed from one person to another through sex, close skin contact, shared towels, or toilet seats, so if you are wondering whether vulvar keratoacanthoma can spread, the answer is no.
Instead, vulvar keratoacanthoma is a growth that develops in the skin itself, and it is not usually thought of as an inherited condition either. People with vulvar keratoacanthoma do not need to isolate from partners or family, but any new vulvar lump should still be checked by a clinician because other conditions can look similar.
When to test your genes
For vulvar keratoacanthoma, genetic testing is not part of routine early detection or treatment planning. It may be worth discussing only if you or close relatives have had many unusual skin tumors, very early cancers, or a known inherited cancer syndrome.
Diagnosis
Vulvar keratoacanthoma is usually diagnosed after a new lump on the vulva appears and grows fairly quickly, often over weeks. It can look like other vulvar growths, including skin cancer, so doctors usually need a close exam and a tissue sample to tell the difference. Many people feel relief just knowing what’s really going on. Because of that, the diagnosis of vulvar keratoacanthoma often depends on both how the spot looks and what the cells show under a microscope.
A clinician looks closely at the vulvar lump, including its size, shape, surface, and how fast it has changed. Vulvar keratoacanthoma often appears as a dome-shaped growth with a central plug of keratin, but appearance alone is not enough to confirm it.
Doctors ask when the bump first appeared, how quickly it grew, and whether there is pain, bleeding, itching, or discharge. A detailed family and health history can help rule out other skin conditions or growths linked to irritation, infection, or prior cancers.
A biopsy is usually the key test for how vulvar keratoacanthoma is diagnosed. The doctor removes part or all of the growth so a pathologist can examine the tissue under a microscope and check for features that overlap with squamous cell carcinoma.
Under the microscope, pathologists look for the typical crater-like structure and the type of keratin in the center of the lesion. They also assess whether the cells look more aggressive, because some lesions that resemble keratoacanthoma are actually cancerous.
How is Vulvar keratoacanthoma diagnosed?
Vulvar keratoacanthoma is usually diagnosed after a clinician examines the lump and asks how quickly it appeared, because these growths often come up fast and can look like other vulvar skin problems. In most cases, the key step is a biopsy, which means removing part or all of the growth so a doctor can look at it under a microscope and tell whether it is this condition or a skin cancer with a similar look. Genetic testing is not usually part of diagnosis.
Stages of Vulvar keratoacanthoma
Vulvar keratoacanthoma often follows a fairly typical course rather than many separate stages. In daily life, this can mean a bump on the vulva appears quickly over days to weeks, then may stop changing for a time. The early symptoms of vulvar keratoacanthoma are often a fast-growing, dome-shaped lump that can feel tender or become irritated by clothing or sitting. Doctors usually confirm what it is with an exam and, in most cases, a biopsy because it can look similar to other vulvar growths.
Growth stage
The lump usually appears quickly and gets larger over a short period, often developing a central plug of keratin, a firm material found in skin. Many living with vulvar keratoacanthoma notice that rubbing, walking, or underwear can make the area more uncomfortable.
Stable stage
After the rapid growth phase, the lesion may stop enlarging for a while and look relatively unchanged. Even at this stage, it still needs medical assessment because it can resemble vulvar squamous cell carcinoma.
Regression stage
Some keratoacanthomas can start to shrink on their own over time. On the vulva, however, doctors usually recommend removal or close evaluation rather than waiting, because spontaneous regression is not reliable and the diagnosis needs to be certain.
Outlook and prognosis
The outlook for vulvar keratoacanthoma is generally excellent when the lesion is completely excised, with most patients cured and recurrence uncommon. Many keratoacanthomas on other body sites may regress spontaneously, but on the vulva they are usually removed because they can closely mimic well-differentiated squamous cell carcinoma and need histologic confirmation. Prognosis depends mainly on accurate diagnosis and complete treatment rather than on long-term aggressive behavior. Death from a true vulvar keratoacanthoma would be exceptionally unlikely, and mortality is not considered a typical feature of this condition. Ongoing follow-up may be advised to watch for local recurrence or to ensure that an underlying malignancy was not missed.
Long-term effects
Vulvar keratoacanthoma is uncommon, and for many people the long-term outlook is good once the growth has been removed and examined. The main lasting issues are usually local, such as discomfort before treatment, healing changes afterward, and the need to make sure it was not a skin cancer look-alike. It’s important to remember that long-term doesn’t always mean progressive, because many living with vulvar keratoacanthoma do not go on to have ongoing health problems from the lesion itself.
Before treatment, the growth can cause soreness, tenderness, itching, or rubbing discomfort with walking, exercise, or sex. These problems usually improve after the lesion is removed or settles.
Long-term effects can include a small scar, changes in skin texture, or ongoing sensitivity in the treated area. On the vulva, even a small change can feel noticeable during daily hygiene, sitting, or intimacy.
One of the biggest long-term concerns is that vulvar keratoacanthoma can closely resemble squamous cell skin cancer. Even after the early symptoms of vulvar keratoacanthoma are gone, doctors often rely on pathology results and follow-up to confirm the outlook is reassuring.
Some people may develop another similar growth in the same area or nearby, although this is not common. If a new lump appears or the area starts changing again, it usually needs prompt reassessment rather than watchful waiting alone.
How is it to live with Vulvar keratoacanthoma?
Living with vulvar keratoacanthoma can be unsettling because it often appears as a fast-growing lump in a very private, sensitive area, which may bring pain, irritation, bleeding, or discomfort with sitting, walking, urination, or sex. For many people, the daily burden is not only physical but emotional too, with worry about cancer, embarrassment, and the strain of needing prompt gynecologic or dermatologic evaluation and usually treatment to remove the lesion. Partners and close family may also feel anxious, but clear communication and timely medical care usually help people move from fear and disruption toward relief and recovery.
Treatment and drugs
Vulvar keratoacanthoma is usually treated by removing the growth, most often with a small surgical procedure, because it can look very similar to a skin cancer and needs to be checked under a microscope. In practice, treatment for vulvar keratoacanthoma often starts with a biopsy or complete excision, which both confirms the diagnosis and removes the lesion. Doctors do not usually rely on watchful waiting in this area, even though keratoacanthomas on other parts of the body can sometimes shrink on their own. Treatment plans often combine several approaches. After removal, follow-up visits help make sure the area is healing well and that there are no signs the growth has come back.
Can you cure Vulvar keratoacanthoma?
Yes, vulvar keratoacanthoma can often be cured if the growth is removed completely, usually with a small surgery. Doctors usually treat it this way because it can look very similar to a more serious skin cancer, so the removed tissue is also checked closely in the lab. After treatment, follow-up visits may help make sure it has not come back.
Non-drug treatment
A fast-growing vulvar lump can make everyday things like walking, sitting, or using the bathroom uncomfortable, so care usually focuses on getting a clear diagnosis and removing the growth safely. With vulvar keratoacanthoma, doctors often treat it much like a possible skin cancer at first, because it can look very similar under the naked eye. For many, treatment begins not at the pharmacy, but with a biopsy and a procedure to take the lesion out. Non-drug care also includes wound care, follow-up skin checks, and practical support while the area heals.
A tissue sample is usually the first step because vulvar keratoacanthoma can closely resemble squamous cell carcinoma. This helps confirm the diagnosis and guide the safest treatment for vulvar keratoacanthoma.
Complete excision is the main non-drug treatment and is often recommended even if the growth seems small. Removing it can both treat symptoms and make sure no cancerous changes are missed.
In some cases, doctors use techniques that check the edges of the removed tissue during or after surgery. This can be especially helpful in the vulva, where preserving as much healthy tissue as possible matters for comfort and function.
After a biopsy or excision, gentle cleansing, keeping the area dry, and avoiding friction can support healing. Some may find loose cotton underwear and avoiding scented products make daily life more comfortable.
Your genes may have an impact on how drugs work for you
For people living with vulvar keratoacanthoma, treatment is usually based on removing the growth and checking it closely under a microscope, so inherited genetic differences do not usually play a major role in how treatment works. In the uncommon situation where medicine is used instead of, or along with, a procedure, there is no well-established evidence that routine genetic testing helps predict which treatment will work best for this condition. In short, for this condition, the main issues are getting the right diagnosis and choosing the safest treatment, rather than how your genes affect drug response.
Pharmacological treatments
For vulvar keratoacanthoma, medicine is usually not the main treatment because the growth is often removed to both treat it and make sure it is not a skin cancer that looks similar. When drugs are used, they are usually considered only if surgery is not a good option, if the lesion is very large, or if treatment is being tailored case by case. Because this condition is rare, there is no single standard drug plan for everyone. If one option isn’t effective, second-line or alternative drugs may be offered.
Methotrexate can be injected into the lesion and is the best-known medicine used for keratoacanthoma when surgery is difficult or needs to be delayed. It works by slowing the fast-growing skin cells inside the bump.
5-fluorouracil, often called 5-FU, may also be injected into the lesion as a local treatment. Some doctors consider it when looking for a non-surgical option for early treatment of vulvar keratoacanthoma, although experience is limited.
Imiquimod is a prescription cream that helps the immune system react against abnormal skin cells. It has been used for some keratoacanthoma-like lesions, but on vulvar skin it can cause marked irritation, so it is not a routine first choice.
Oral retinoids such as acitretin or isotretinoin have occasionally been used for people with multiple or recurring keratoacanthoma-type lesions. For a single vulvar keratoacanthoma, they are not standard treatment and would usually be considered only in unusual situations.
Genetic influences
When a new vulvar growth appears, many people worry about whether it could be inherited, but vulvar keratoacanthoma usually does not have a clear family-based genetic cause. It’s natural to ask whether family history plays a role. In most cases, these growths seem to happen sporadically, likely from gene changes that develop only in the affected skin cells rather than ones passed down from a parent. Rarely, people who develop multiple keratoacanthomas in different places on the body may have an inherited condition that raises the risk of this kind of growth. For many living with vulvar keratoacanthoma, this means genetic testing is not routinely needed, but a doctor may think more about genetics if there are repeated lesions, a strong family history of similar skin tumors, or a family history of certain cancers.
Is Vulvar keratoacanthoma genetic?
Genetics are not thought to play a major role in vulvar keratoacanthoma. Most cases are not inherited, and no specific genetic variation is known to clearly cause it, though rare tumor-related DNA changes may be found.
Having a genetic risk is not necessarily a diagnosis
Changes in genes, often called genetic variants, are a usual part of human biology and are common throughout the general population. Most of these variants do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant linked with a condition suggests a possible association rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some cases, however, a single well-understood variant in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
Because vulvar keratoacanthoma often appears as a fast-growing lump in a very sensitive area, treatment usually focuses on removing it promptly and checking it closely under a microscope, rather than relying on long-term drug therapy. For most people with vulvar keratoacanthoma, this means a minor procedure is more important than genetics when deciding care. Genetics is only one factor, and for this rare growth there are no well-established gene-based drug choices that are routinely used in everyday practice. Inherited differences can still affect how your body handles medicines used around treatment, such as local anesthetics, pain relievers, or antibiotics, so side effects or dose needs may vary from one person to another. This is why the treatment of vulvar keratoacanthoma is usually guided more by the size and look of the growth, its exact diagnosis, and your overall health than by a genetic test. If you have had unusual reactions to medicines in the past, letting your doctor know can help them choose the safest options during treatment.
Interactions with other conditions
With vulvar keratoacanthoma, the main issue is usually not that it directly affects other organs, but that it can look very similar to other vulvar conditions that need different treatment. In particular, vulvar keratoacanthoma can closely resemble vulvar squamous cell carcinoma, so a biopsy is often needed to tell them apart. Certain diseases may overlap, meaning long-standing skin irritation or inflammatory vulvar conditions can make the area harder to assess and may delay recognition of a new growth. People with immune system problems may also need especially careful follow-up, since unusual skin growths can behave less predictably in that setting. If you are wondering about the early symptoms of vulvar keratoacanthoma, the safest approach is to have any fast-growing, tender, or crater-like vulvar lump checked promptly so it is not mistaken for another disease.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Vulvar keratoacanthoma?
A fast-growing lump on the vulva can be confused with vulvar skin cancer, especially squamous cell carcinoma, because both can look like a firm raised bump with a crust, plug, or sore in the center. Genital warts, an infected hair follicle or boil, and a blocked gland cyst such as a Bartholin cyst can also cause a new vulvar lump, pain, or irritation. Because these problems can look so similar, a clinician often needs to examine the area closely and sometimes take a small tissue sample to tell them apart.
History
Finding a new lump on the vulva can be unsettling, especially when it seems to grow quickly over days or weeks. That pattern is one reason vulvar keratoacanthoma has drawn medical attention: many living with it notice a dome-shaped bump with a central plug of keratin, the same protein that helps make up skin, hair, and nails. Because the early symptoms of vulvar keratoacanthoma can overlap with other vulvar growths, doctors have long relied on careful examination and a tissue sample to sort out what it is.
Reports of keratoacanthoma first appeared in the skin literature before doctors began describing the much rarer vulvar form. Once considered rare, now recognized as a distinct clinical and pathology problem, vulvar keratoacanthoma has also been difficult to classify with complete confidence. Over time, specialists noticed that some of these growths behaved in a way that looked relatively limited, while others closely resembled a type of skin cancer called squamous cell carcinoma under the microscope. That overlap shaped the history of the condition and is still part of why prompt assessment matters.
As medical science evolved, the way vulvar keratoacanthoma was understood became more nuanced. Earlier descriptions focused mostly on how the growth looked and how fast it appeared, while later work added better pathology criteria and a clearer sense that vulvar lesions need cautious evaluation rather than assumptions. Researchers also came to appreciate that although keratoacanthomas on other parts of the body may sometimes shrink on their own, growths on the vulva are usually managed more actively because the area is delicate and because ruling out cancer is so important.
Today, the history of vulvar keratoacanthoma is less about a single discovery and more about a gradual sharpening of medical judgment. What used to be grouped loosely with other fast-growing skin nodules is now approached as a lesion that deserves expert review, both for comfort and for safety. Knowing that background can help explain why your care team may recommend biopsy or removal even if the growth appeared suddenly and does not seem severe at first.